80 Results for "

GluR

" in MedChemExpress (MCE) Product Catalog:
Products (80)

80 Results for "GluR" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-B0122
CAS No.: 97240-79-4
Synonyms: McN 4853; RWJ 17021
Topiramate (McN 4853) is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-19904
CAS No.: 1488363-78-5
Synonyms: LY2409021
Target:  

GCGR

Research Areas:  

Metabolic Disease

Adomeglivant (LY2409021) is a potent, selective glucagon receptor (GluR) allosteric antagonist. Adomeglivant is widely used in the research for type 2 diabetes mellitus .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-B1752
CAS No.: 80373-22-4
Synonyms: LY 171555; (-)-LY 141865
Quinpirole (LY 171555; (-)-LY 141865) is a D2/D3 dopamine receptor agonist and a CaV1.3 calcium channel modulator. Quinpirole normalizes dendritic spine density in dopamine-depleted striatum, upregulates the protein expression of BCL2 and GluR2, downregulates the protein expression of BAX, and delays the onset of seizures. Quinpirole enhances learning and memory, inhibits neuronal apoptosis (apoptosis), and induces anxiety-like, stereotyped, and compulsive behaviors. Quinpirole disrupts prepulse inhibition in rhesus monkeys, enhances the activity of paraventricular thalamic neurons to promote recovery from Isoflurane anesthesia, and alters the composition of the gut microbiota in rats. Quinpirole can be used in research related to dyskinesia, pain, epilepsy, and neurological disorders including anxiety disorder, obsessive-compulsive disorder, and schizophrenia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-114427
CAS No.: 136623-01-3
Purity:  98.00%
Target:  

iGluR

Research Areas:  

Neurological Disease

NS-102 is a selective kainate (GluK2) receptor antagonist. NS-102 is a potent GluR6/7 receptor antagonist .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107604
CAS No.: 745055-91-8
Purity:  99.75%
Target:  

iGluR

Research Areas:  

Neurological Disease

UBP 302 is a potent and selective GLUK5-subunit containing kainate receptor antagonist (apparent Kd=402 nM), and displays very little affinity on GluK2 (GluR6) kainate receptors. Anxiolytic effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P4106A
Research Areas:  

Neurological Disease

Tat-GluR23Y, scrambled TFA is the scrambled peptide of Tat-GluR23Y (HY-P2259). Tat-GluR23Y is a synthetic peptide containing tyrosine residues that inhibit AMPAR endocytosis and is effective in the research of long-term depression (LTD) .
loading...
    loading...
Cat. No.: HY-107602
CAS No.: 902464-46-4
Purity:  99.82%
Target:  

iGluR

Research Areas:  

Neurological Disease

UBP310 is a selective GluR5 antagonist, with a Kd of 130 nM .
loading...
    loading...
Cat. No.: HY-107601
CAS No.: 936095-50-0
Purity:  99.95%
Synonyms: ACET
Target:  

iGluR

Research Areas:  

Neurological Disease

UBP316 (ACET) is a highly potent and selective kainate receptor GluK1 (GluR5) antagonist, with a Kb value of 1.4 nM. UBP316 is effective at blocking the depression of both field excitatory postsynaptic potentials (fEPSPs) and monosynaptically-evoked GABAergic transmission induced by ATPA, a GluK1 selective agonist .
loading...
    loading...
Cat. No.: HY-101528
CAS No.: 22503-72-6
Purity:  99.33%
Target:  

iGluR

Research Areas:  

Neurological Disease

IDRA 21 is a positive and orally active modulator of the AMPA receptor. IDRA 21 facilitates excitatory neurotransmission via GluR1/2 receptors. IDRA 21 has the potential for the research of cognitive/memory disorders, including those associated with aging .
loading...
    loading...
Cat. No.: HY-12509
CAS No.: 141286-78-4
Purity:  99.87%
Target:  

iGluR

Research Areas:  

Neurological Disease

PEPA is an AMPA receptor allosteric potentiator. PEPA shows preferential action of PEPA on the flop form of AMPA receptors. PEPA is a more potent suppressor of desensitization of receptors containing GluR3 and GluR4 as opposed to those containing GluR1. PEPA has antianxiety effects .
loading...
    loading...
Cat. No.: HY-104020A
CAS No.: 1227301-51-0
Purity:  99.72%
Synonyms: PhTx 74 dihydrochloride
Target:  

iGluR

Research Areas:  

Neurological Disease

Philanthotoxin 74 dihydrochloride (PhTx 74) is an AMPAR antagonist; inhibits GluR3 and GluR1 with IC50s of 263 and 296 nM, respectively .
loading...
    loading...
Cat. No.: HY-101261
CAS No.: 140158-50-5
Purity:  ≥96.0%
Target:  

iGluR

Research Areas:  

Neurological Disease

ATPA is a selective glutamate receptor GluR5 activator with EC50s of 0.66, 9.5, 1.4, 23, 32, 18, and 14 μM for GluR5wt, GluR5(S741M), GluR5(S721T), GluR5(S721T, S741M), GluR5(S741A), GluR5(S741L), and GluR5(S741V), respectively .
loading...
    loading...
Cat. No.: HY-13456
CAS No.: 211311-95-4
Purity:  98.27%
Target:  

iGluR

Research Areas:  

Neurological Disease

LY-404187 is a potent, selective and centrally active positive allosteric modulator of AMPA receptors, with the EC50s of 5.65, 0.15, 1.44, 1.66 and 0.21 µM for GluR1i, GluR2i, GluR2o, GluR3i and GluR4i, respectively. LY-404187 has therapeutic potential in a number of psychiatric disorders and neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-P1195
CAS No.: 1315378-73-4
Target:  

iGluR

Research Areas:  

Neurological Disease

PDZ1 Domain inhibitor peptide, a cyclic peptide, incorporates a β-Ala lactam side chain linker and targets the PDZ1 domains of the postsynaptic density protein 95 (PSD-95). PDZ1 Domain inhibitor peptide disrupts the GluR6/PSD-95 interaction and is very efficient in competing against the C terminus of GluR6 for the PDZ1 domain .
loading...
    loading...
Cat. No.: HY-B0122R
CAS No.: 97240-79-4
Synonyms: McN 4853 (Standard); RWJ 17021 (Standard)
Topiramate (Standard) is the analytical standard of Topiramate. This product is intended for research and analytical applications. Topiramate (McN 4853) is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase .
loading...
    loading...
Cat. No.: HY-147132
CAS No.: 323176-64-3
Purity:  ≥98.0%
Target:  

iGluR

Research Areas:  

Neurological Disease

GluR6 antagonist-1 is a benzothiophene derivative, acting as a GluR6 antagonist. GluR6 antagonist-1 can be used for researching acute and chronic neurological disorders .
loading...
    loading...
Cat. No.: HY-19433A
CAS No.: 252930-37-3
Target:  

iGluR

Research Areas:  

Neurological Disease

(S)-ATPO is the (S)-enantiomer of ATPO, which is a competitive antagonist at GluR1-4 (AMPA-preferring) receptors .
loading...
    loading...
Cat. No.: HY-103229
CAS No.: 909400-43-7
Purity:  ≥99.0%
Target:  

iGluR

Research Areas:  

Neurological Disease

Cl-HIBO is a highly subtype-selective GluR1/2 agonist (EC50=4.7 and 1.7 μM, respectively). Cl-HIBO is a potent AMPA receptor agonist (IC50=0.22 μM). Cl-HIBO has desensitizing properties .
loading...
    loading...
Cat. No.: HY-B0122S
Synonyms: McN 4853-13C6; RWJ 17021-13C6
Topiramate-13C6 (McN 4853-13C6) is the 13C labeled isotope of Topiramate (HY-B0122). Topiramate (McN 4853) is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase .
loading...
    loading...
Cat. No.: HY-176297
CAS No.: 620113-98-6
Target:  

AMPK iGluR

Research Areas:  

Neurological Disease

Tezampanel etibutil is an orally active AMPA/GluR antagonist. Tezampanel etibutil can be used in the research of pain, migraine, and neurological disorders .
loading...
    loading...